Windtree Therapeutics, a Nasdaq listed biotechnology company, has plans to raise up to $200 million to build a treasury of ...

Anthem Biosciences Ltd.'s ₹3,395-crore initial public offering (IPO) in 2025 was oversubscribed by 63.86 times due to strong ...

At the facility developed in partnership with the distillery, Meridian Biotech will convert Buffalo Trace's by-products ...

The initial public offer of Anthem Biosciences received bids for 2,81,45,24,128 shares as against 4,40,70,682 shares on offer. The issue was subscribed 63.86 times.

The allotment for Anthem Biosciences IPO is now complete. Investors can check their status on KFin Technologies website. The ...

Niagen Bioscience CEO Robert Fried discusses the science of NAD, the problems with the supplement industry, and how his company is leading the way in anti-aging research.

The company will also add a warning label to its drug Elevidys after the deaths of two teenage patients this year.

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Some of the most high-profile acquisitions in recent years have involved women-fronted biotechs. BioSpace reviews five of the ...

Cogent Biosciences, Inc. (NASDAQ:COGT) is one of the 10 Best Small-Cap Stocks to Buy According to Billionaires. On July 7, ...

Aptorum Group has agreed to combine with molecular-diagnostics company DiamiR Biosciences in an all-stock reverse merger. Clinical-stage biopharmaceutical company Aptorum said its shareholders will ...

Satellos Bioscience ( TSX: MSCL:CA) appointed Wildon Farwell, M.D., MPH, as chief medical officer. Dr. Farwell joins Satellos from Dyne Therapeutics ( DYN ), where he most recently served as CMO and ...